Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Junaid Malek

Vascular Surgery Providence, RI Medical Doctor

NPI 1487769162 CMS profile 340076

195 Collyer St, Suite 302, Providence, RI 02904

Open in the dashboard

General payments

$14,437

68 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Junaid Malek of Providence, RI is reported in the CMS Open Payments database as having received $14,437 across 68 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 76th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $24 1
2024 General $2,929 6
2023 General $717 11
2022 General $6,170 23
2021 General $2,437 9
2020 General $1,348 6
2019 General $812 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Junaid Malek
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Junaid Malek were reported at $24. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Junaid Malek Vascular Surgery median Middle half National median
2019 $812 $796 $226–$2,363 $163
2020 $1,348 $348 $118–$1,110 $114
2021 $2,437 $471 $158–$1,421 $132
2022 $6,170 $725 $222–$2,183 $149
2023 $717 $836 $257–$2,440 $160
2024 $2,929 $909 $252–$2,619 $164
2025 $24 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cook Incorporated $6,600 3 payments
  2. Cardiovascular Systems Inc. $3,433 7 payments
  3. Cook Medical LLC $1,955 27 payments
  4. Penumbra, Inc. $1,021 7 payments
  5. W. L. Gore & Associates, Inc. $593 7 payments
  6. Endologix, Inc. $482 9 payments
  7. CryoLife, Inc. $141 1 payment
  8. Medtronic Vascular, Inc. $86 1 payment
  9. Tactile Systems Technology Inc $24 1 payment
  10. Silk Road Medical, Inc. $24 1 payment
  11. Other $78 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,600 3 payments
  2. Food and Beverage $3,929 57 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $2,000 1 payment
  4. Travel and Lodging $1,033 6 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $875 1 payment
Products named General payments · program years 2019–2025
  1. Zilver PTX $5,205 13 payments
  2. Diamondback Peripheral $2,133 2 payments
  3. COOK $2,100 1 payment
  4. Peripheral Orbital Atherectomy System $1,151 4 payments
  5. RUBY Coil $1,013 6 payments
  6. Alto Abdominal Stent Graft System $240 4 payments
  7. ZENITH ALPHA $216 3 payments
  8. Cook Medical Zilver PTX $216 2 payments
  9. SEAMGUARD Bioabsorbable Staple Line Reinforcement $192 2 payments
  10. Zenith $189 3 payments
  11. Other $1,666 29 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 63 billing codes

Paid by Medicare

$30,692

Medicare's payments for the services billed

Medicare patients

147

Average age 75

Services billed

254

75 women, 72 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Ischemic heart disease 40%
Diabetes 39%
Chronic kidney disease 33%
Depression 29%
Atrial fibrillation 27%
COPD 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

68 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record